Results 201 to 210 of about 1,172,272 (355)

Selecting initial therapy for prostate cancer. Radiation therapy perspective [PDF]

, 1987
Malcolm A. Bagshaw, Gordon R. Ray, Richard S. Cox   +2 more
openalex   +1 more source

Peptide Amphiphiles Hitchhike on Endogenous Biomolecules for Enhanced Cancer Imaging and Therapy

Advanced Materials, EarlyView.
Weakly assembled peptide amphiphile nanostructures disassemble in circulation and reassemble with blood biomolecules, mainly lipoproteins. Binding to blood biomolecules prolongs blood circulation and improves accumulation in solid tumors. In the tumor microenvironment, peptide amphiphiles assemble with cholesterol‐rich domains of cell membranes ...
Li Xiang, Morgan R. Stewart, Kailin Mooney, Mingchong Dai, Samuel Drennan, Samantha Holland, Arnaud Quentel, Sinan Sabuncu, Benjamin R. Kingston, Isabel J. Dengos, Karla Bonic, Florian Goncalves, Xin Yi, Michael I. Henderson, Srivathsan Ranganathan, Bruce P. Branchaud, Leslie L. Muldoon, Ramon F. Barajas Jr, Jared M. Fischer, Adem Yildirim   +19 more
wiley   +1 more source

The natural history of prostate cancer. [PDF]

Can Urol Assoc J
O'Connell C, Bernardino RM, Fleshner NE.
europepmc   +1 more source

Kinetic analysis of prostatic volume in treating prostatic cancer and its predictability for prognosis [PDF]

, 1988
Hiroshi Ohe, Hiroki Watanabe
openalex   +1 more source

Advances and Strategies in Enhancing mRNA Cancer Vaccines

Advanced Materials, EarlyView.
Messenger RNA (mRNA) vaccines offer a powerful approach for cancer immunotherapy, but their clinical impact remains limited by delivery challenges and suboptimal immune activation. This review discusses key biological barriers and design strategies—including structural optimization, immunomodulation, organ targeting delivery, and advanced nanocarriers ...
Miao Zhang, Shengqi Chen, Haijun Hu, Yenhui Ong, Qianqian Ni   +4 more
wiley   +1 more source

Oesophageal metastasis of prostate cancer: a case report. [PDF]

Discov Oncol
Shi YJ, Yang YS, Ren DB, Jing W.
europepmc   +1 more source

Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system. [PDF]

, 1984
G. Williams, D. Kerle, Stacy Griffin, HELEN DUNLOP, S. R. Bloom   +4 more
openalex   +1 more source

Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects

Advanced Materials, EarlyView.
Mesoporous silica nanoparticles offer unique properties like high surface area, tunable pores, and functionalization. They excel in drug delivery, tissue engineering, and stimuli‐responsive therapies, enabling targeted and controlled treatments. With roles in cancer therapy and diagnostics, their clinical translation requires addressing challenges in ...
Miguel Manzano, María Vallet‐Regí
wiley   +1 more source

Novel biomarkers for prognosis in patients with localized prostate cancer. [PDF]

Oncol Lett
Goulielmaki M, Stokidis S, Anagnostou T, Gritzapis AD, Tsitsilonis OE, Baxevanis CN, Fortis SP.   +6 more
europepmc   +1 more source

New Management Strategies of Hormone Refractory Prostate Cancer (HRPC)

, 1970
MA Salam
openalex   +2 more sources